Arca
Skip to content

Warning Letter to Front Range Kratom

Unspecified. See Front Range Kratom's company page or this site's inspections.

On May 18, 2018, FDA's CDER sent Front Range Kratom a warning letter citing unapproved new drug, marketing claims, labeling.

  • Letter date: May 18, 2018
  • Issued by: CDER
  • Closeout: —

The Letter

As posted on FDA.gov ↗; cited 21 CFR sections link to their page.

• “I have a lot of people coming in and asking about how Front Range Kratom in Denver could help them with various things. For me, the two things I think kratom works the best for are pain and to help people get through some of the post acute withdrawl (sic) symptoms they get when they come off of their pain medications.”

• “Certainly kratom is useful for pain — myself and everyone else on the internet can attest to that. But as someone who has experienced the withdrawl (sic) type symptoms from coming off of opiates, I can tell you that getting through the depression... is the hardest part. I have found personally that kratom is useful for this and you can read on reddit and everywhere else on the internet other people's experiences.”

• “Bali red vein kratom powder has been used for centuries for the treatment of pain and opiate addiction in the far east.”

• March 18 posting: “Along with helping drug addiction, the health benefits of kratom leaves include their ability to lower blood pressure, relieve pain, boost metabolism, increase sexual energy, improve the immune system, prevent diabetes, ease anxiety, eliminate stress, and induce healthy sleep.”

• March 11 posting: “Great post from ER doc on how Kratom is vital to helping people with opiate addiction”

• February 20 posting: “Chris Bell: Kratom Is the Cure for the Opioid Epidemic”

• March 11 posting: “How Kratom is helping with opiate addiction from someone on front lines”

Recent Letters Citing Unapproved new drug

See them all

Record

Recipient
Gregory Todd Schulte
FDA site ID (FEI)
3014323888

Tags are assigned by Arca from the letter's text. A closeout letter means FDA found the firm's corrections adequate; no closeout does not mean the issues are unresolved. FDA warning letters

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.